image description

Tag: American College of Rheumatology

Pivotal LRA-Funded Research Shared at Annual Rheumatology Meeting

November 15, 2021 The Lupus Research Alliance (LRA) supports research into causes and mechanisms of lupus, and identification of targets supporting the development of new therapies or cures for lupus patients. At this year’s meeting of the American College of Rheumatology (ACR), 17 LRA-funded researchers presented their work to share discoveries with the thousands of […] Read More

Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting

November 9, 2021 Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2021, November 3-9. Bringing you the most relevant news for our lupus community, following are summaries of key research presented at the meeting: New Data on Approved Lupus Treatments […] Read More

LRA Summarizes ACR Guidelines On COVID-19 Vaccines

September 22, 2021 Should people with lupus be vaccinated against COVID-19? Should people with lupus take the third dose of the Pfizer/Biogen or Moderna mRNA COVID-19 vaccine? Do people with lupus qualify as immunocompromised? How can people with lupus protect themselves from COVID-19? Many of you have had these questions and more since the U.S. […] Read More

New COVID-19 Vaccine Clinical Guidance and Planned Research

Important news for people with lupus as COVID-19 vaccines are on everyone’s minds.  The foremost authority in rheumatologic diseases, the American College of Rheumatology (ACR) recently issued the COVID-19 Vaccine Clinical Guidance. Developed by a panel of rheumatologists, specialists in infectious disease and public health experts, the Guidance aims to help healthcare providers make decisions with their […] Read More

Third Vaccine Shield Against COVID-19 Rolling Out March 1, 2021

March 1, 2021 Americans gained a third weapon against COVID-19 this weekend with the availability of a third vaccine. On February 27, 2021, the U.S. Food and Drug Administration granted Emergency Use Authorization to the new vaccine from Janssen Pharmaceutical Companies of Johnson & Johnson to prevent COVID-19 in adults age 18 and older. The […] Read More

New Guidelines from the ACR For Lupus Care During COVID-19 Pandemic

June 9, 2020 The American College of Rheumatology enlisted 14 experts on infectious diseases and immune system illnesses to develop and publish 25 recommendations on treating lupus and related immune system diseases amid the COVID-19 pandemic.  The Lupus Research Alliance would like to share these with the lupus community as information, but recommend talking to […] Read More

COVID-19 Frequently Asked Questions: What You Should Know

Updated April 3, 2020 The first priority of the Lupus Research Alliance is the health of our lupus community.  We have been consulting with health care authorities and monitoring the situation created by the spread of COVID-19. Please note that every lupus patient is different. If you have specific questions about your condition and/or any […] Read More

LRA Sponsors COVID-19 Global Rheumatology Alliance

March 25, 2020 LRA Sponsors COVID-19 Global Rheumatology Alliance The LRA is proud to be among the sponsors of the COVID-19 Global Rheumatology Alliance, a grassroots group led by rheumatologists and uniting rheumatologists and patients with rheumatic diseases worldwide to respond to the global pandemic. In concert with the American College of Rheumatology, the group’s […] Read More

Coronavirus Disease Info for People with Lupus

Updated March 11, 2020 On behalf of our lupus community, the Lupus Research Alliance is following closely reports from the U.S. Centers for Disease Control and Prevention (CDC), the country’s health protection agency, about the Coronavirus Disease 2019 called COVID-19. People with lupus are predisposed (at greater risk) to infections because of both their disease […] Read More

LRA-Funded Scientists Command Attention at 2019 ACR/ARP

November 14, 2019 The Lupus Research Alliance was proud of the unprecedented number of the studies supported by the Alliance chosen for presentation at the 2019 ACR/ARP Annual Meeting, the world’s largest rheumatology conference. A total of 19 studies were shared in oral presentations to large audiences, while 13 were presented as posters, which allow […] Read More